The in vivo loss of SMARCA4 results in the hypoplastic development of the pancreas [46] and enhances IPMN formation from the duct cell while suppressing PanIN formation from acinar cells carrying KRasG12D mutation [46]. This evidence concerns the gene SMARCA4 and pancreatic intraductal papillary-mucinous neoplasm.